Board of Directors
Chairman: Tessie Che, Ph.D.
Dr. Tessie Che is currently serving as General Manager of Amaran Biotechnology. Dr. Che received her Ph.D. in physical-inorganic chemistry from Brandeis University, Waltham, Massachusetts and conducted post-doctoral research at Columbia University, New York, New York. read more..
Director: Frank Chen
Mr. Chen is currently serving as Vice General Manager, Investment Management and Special Assistant to Chairman of Ruentex Group. He obtained his Master degree in Business Administration from National Taiwan University.
Director: Tamon Tseng, LLM.
Mr. Tseng joined Ruentex Group in 1992, and is currently serving as Special Assistant to the CEO of Ruentex Industries, Ltd. Mr. Tseng was called to the English Bar in 1985. He received a B.A. from the University of Cambridge, an LL.M. from University College London, and an LL.B. from National Chengchi University.
Director: Heidi Wang, Ph.D.
Dr. Heidi Wang graduated from the University of Notre Dame in Indiana, USA with a M.S. and a Ph.D. in molecular biology and virology. She also received postdoctoral training in cancer biology at the Cold Spring Harbor Laboratory in New York, USA. Dr. Wang is a world-renowned drug regulatory expert, she served as Vice President and Head of Global Regulatory Sciences Oncology at Bristol-Myers Squibb (BMS) Company.
Director: Ming-Tain Lai, Ph.D.
Dr. Ming-Tain Lai is currently serving as Chief Scientific Officer of OBI Taiwan. Dr. Lai received his Ph.D. in Bio-Organic Chemistry from University of Minnesota and conducted post-doctoral research at Massachusetts Institute of Technology (MIT), USA. As Senior Principal Scientist at Merck & Co., Dr. Lai led and directed multiple independent project teams to develop potential clinical candidates.